Stroke Drug Kills Cancer Cells and Leaves Normal Cells Intact, Tel Aviv University Study

Bookmark and Share

Tel Aviv University -- A never-approved drug developed to prevent the death of nerve cells after a stroke can efficiently kill cancer cells while keeping normal cells healthy and intact, an international team led by a Tel Aviv University researcher is reporting in the journal Breast Cancer Research.

Back to news